1/11/2018
Flublok Quadrivalent Influenza vaccine is now available to order for the 2018-2019 influenza season. Flublok is indicated for adult patients 18 years of age and older. In a recent study published in the New England Journal of Medicine, in patients 50 years of age and older, Flublok was found to be 30%-43% more effective in preventing influenza disease than the standard dose quadrivalent influenza vaccine. Flublok contains 3x the hemagglutinin antigen (HA) content (45 mcg per strain) compared to a standard-dose influenza vaccine (15 mcg HA per strain ).